Erlotinib 68382-0915-16
- Manufacturer
- Zydus Pharmaceuticals Usa Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 30, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213065
Need to source Erlotinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erlotinib Hydrochloride | 150 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Selected Package
68382-0915-16Selected90 TABLET in 1 BOTTLE (68382-915-16)
Other packages for this product(2)
30 TABLET in 1 BOTTLE (68382-915-06)
3 BLISTER PACK in 1 CARTON (68382-915-84) / 10 TABLET in 1 BLISTER PACK (68382-915-30)